Highlights and Quick Summary
- Common Stock (Net) for the quarter ending November 30, 2022 was $571 Million (a -5.59% decrease compared to previous quarter)
- Year-over-year quarterly Common Stock (Net) decreased by -5.58%
- Annual Common Stock (Net) for 2022 was $605 Million (a 4.99% increase from previous year)
- Annual Common Stock (Net) for 2021 was $576 Million (a 84.18% increase from previous year)
- Annual Common Stock (Net) for 2020 was $313 Million (a 30.41% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Common Stock (Net) of Organigram Holdings Inc.
Most recent Common Stock (Net)of OGI including historical data for past 10 years.Interactive Chart of Common Stock (Net) of Organigram Holdings Inc.
Organigram Holdings Inc. Common Stock (Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $571.36 | $605.16 | $605.55 | $605.13 | $605.16 |
| 2021 | $584.6 | $576.38 | $581.65 | $383.88 | $576.38 |
| 2020 | $359.78 | $312.94 | $288.36 | $282.95 | $312.94 |
| 2019 | $240.68 | $239.96 | $228.24 | $171.72 | $239.96 |
| 2018 | – | – | $136.12 | $123.57 | $123.57 |
| 2017 | – | – | – | – | $78.51 |
| 2016 | – | – | – | – | $38.9 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic